Gossamer Bio: Executive Compensation & Equity Awards Detailed
Ticker: GOSS · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1728117
| Field | Detail |
|---|---|
| Company | Gossamer Bio, Inc. (GOSS) |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
TL;DR
Gossamer Bio's proxy statement details exec pay and equity awards for 2024, showing PEO & non-PEO grants.
AI Summary
Gossamer Bio, Inc. filed a DEF 14A on April 29, 2025, detailing executive compensation and equity awards for the fiscal year ending December 31, 2024. The filing includes information on performance-based equity awards granted to both principal executive officers (PEO) and non-PEO named executive officers, with values for outstanding and unvested awards as of year-end 2022, 2023, and 2024.
Why It Matters
This filing provides transparency into how Gossamer Bio compensates its top executives, which can influence investor perception of management alignment with shareholder interests.
Risk Assessment
Risk Level: medium — DEF 14A filings related to executive compensation can sometimes reveal information that impacts stock price, especially if compensation structures are perceived as misaligned with company performance.
Key Players & Entities
- Gossamer Bio, Inc. (company) — Filer of the DEF 14A
- 20250429 (date) — Filing date
- 2024-12-31 (date) — Fiscal year end
- 2022-12-31 (date) — Prior fiscal year end for award data
- 2023-12-31 (date) — Prior fiscal year end for award data
FAQ
What is the total value of equity awards granted to PEOs in the fiscal year ending December 31, 2024?
The filing indicates that for the fiscal year 2024, there were equity awards granted to PEO members, but the specific total dollar value is not provided in the excerpt.
How many equity awards were outstanding and unvested for non-PEO members as of December 31, 2024?
The filing mentions 'NonPeoNeoMember' for the year 2024 and 'YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember', suggesting such data exists, but the specific number is not in the provided text.
What is the filing date of this DEF 14A?
The filing date is April 29, 2025.
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by companies to solicit shareholder votes on important corporate matters, often including executive compensation.
What is Gossamer Bio's Standard Industrial Classification (SIC) code?
Gossamer Bio's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding Gossamer Bio, Inc. (GOSS).